![](/img/cover-not-exists.png)
2128 POSTER PTEN, EGFR, MAPK and Akt status by immunohistochemistry (IHC) in HER2-positive (HER2+) metastatic breast cancer (MBC) patients (pts) treated with trastuzumab (T) ± chemotherapy (CT): correlation with clinical outcome
S. Gori, V. De Angelis, A. Sidoni, M. Colozza, I. Ferri, D. Fenocchio, V. Ludovini, C. Basurto, P. Anastasi, L. CrinóVolume:
5
Year:
2007
Language:
english
DOI:
10.1016/s1359-6349(07)70890-x
File:
PDF, 61 KB
english, 2007